HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T S Ganesan Selected Research

DBPT regimen

6/2000Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T S Ganesan Research Topics

Disease

7Neoplasms (Cancer)
02/2017 - 01/2003
6Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 08/2000
3Renal Cell Carcinoma (Grawitz Tumor)
11/2004 - 01/2000
2Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 07/2016
2Lymphoma (Lymphomas)
03/2018 - 07/2016
2Ovarian Epithelial Carcinoma
02/2017 - 06/2006
2Neoplasm Metastasis (Metastasis)
01/2016 - 06/2006
1Tumor Lysis Syndrome
10/2018
1Cardiotoxicity
03/2018
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Multiple Myeloma
10/2017
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2017
1Hodgkin Disease (Hodgkin's Disease)
06/2015
1Lichen Planus (Lichen Ruber Planus)
09/2009
1Necrosis
07/2004
1Vomiting
01/2003
1Sleepiness
01/2003
1Uterine Cervical Dysplasia
09/2000
1Carcinoma (Carcinomatosis)
07/2000
1Colorectal Neoplasms (Colorectal Cancer)
06/2000
1Melanoma (Melanoma, Malignant)
06/2000
1Hypoxia (Hypoxemia)
06/2000

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
10/2003 - 06/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2018 - 06/2015
2DNA (Deoxyribonucleic Acid)IBA
01/2018 - 09/2000
2AntibodiesIBA
02/2017 - 06/2006
2Vinblastine (Vinblastine Sulfate)FDA Link
06/2015 - 01/2000
2Biomarkers (Surrogate Marker)IBA
01/2011 - 12/2000
2Carboplatin (JM8)FDA LinkGeneric
01/2011 - 04/2010
2Paclitaxel (Taxol)FDA LinkGeneric
04/2010 - 07/2005
2Thymidine PhosphorylaseIBA
06/2006 - 07/2000
2Biological FactorsIBA
06/2006 - 08/2000
2Fluorouracil (Carac)FDA LinkGeneric
07/2000 - 06/2000
1Lapatinib (GW572016)FDA Link
01/2022
12- methoxy- N- (3- (4- ((3- methyl- 4- ((6- methyl- 3- pyridinyl)oxy)phenyl)amino)- 6- quinazolinyl)- 2- propenyl)acetamideIBA
01/2022
1PhosphoproteinsIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2021
1Uric Acid (Urate)IBA
10/2018
1rasburicase (Elitek)FDA Link
10/2018
1Urate Oxidase (Uricase)IBA
10/2018
1EnzymesIBA
10/2018
1Epirubicin (Ellence)FDA LinkGeneric
03/2018
1AnthracyclinesIBA
03/2018
1Daunorubicin (Cerubidine)FDA LinkGeneric
03/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2017
1Lenalidomide (CC 5013)FDA Link
10/2017
1Rituximab (Mabthera)FDA Link
04/2017
1Biosimilar PharmaceuticalsIBA
04/2017
1C-Type Lectins (C-Type Lectin)IBA
02/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
06/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2015
1Etoposide (VP 16)FDA LinkGeneric
06/2015
1Prednisolone (Predate)FDA LinkGeneric
06/2015
1Procarbazine (Matulane)FDA Link
06/2015
1Vincristine (Oncovin)FDA LinkGeneric
06/2015
1Thalidomide (Thalomid)FDA Link
01/2011
1Phosphates (Orthophosphate)IBA
04/2010
1combretastatinIBA
04/2010
1Imatinib Mesylate (Gleevec)FDA Link
09/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006
1Hyaluronan ReceptorsIBA
06/2006
1etoposide phosphate (Etopophos)FDA Link
07/2005
1Topotecan (Hycamtin)FDA LinkGeneric
07/2005
1Angiogenesis InhibitorsIBA
11/2004
1Dalteparin (Dalteparin Sodium)FDA Link
07/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2004
1Captopril (Capoten)FDA LinkGeneric
07/2004
1marimastatIBA
07/2004
1tazarotene (Tazorac)FDA Link
09/2003
1BilirubinIBA
01/2003
1acridine DACAIBA
01/2003
1Carbon-11IBA
01/2003
1Topoisomerase II InhibitorsIBA
12/2000
1RazoxaneIBA
12/2000
1Interferon-alpha (Interferon Alfa)IBA
07/2000
1Leucovorin (Folinic Acid)FDA Link
07/2000
1Carmustine (FIVB)FDA Link
06/2000
1Mitomycin (Mitomycin-C)FDA LinkGeneric
06/2000
1TamoxifenFDA LinkGeneric
06/2000
1Cisplatin (Platino)FDA LinkGeneric
06/2000
15-(2-formyl-3-hydroxyphenoxy)pentanoic acidIBA
06/2000
1Oxygen (Dioxygen)IBA
06/2000
1AcidsIBA
06/2000
1Dacarbazine (DIC)FDA LinkGeneric
06/2000
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2000
1Toremifene (Fareston)FDA Link
01/2000

Therapy/Procedure

8Therapeutics
07/2016 - 06/2000
4Drug Therapy (Chemotherapy)
02/2017 - 01/2000
1Transplantation
10/2017
1Combination Drug Therapy (Combination Chemotherapy)
06/2015
1Immunotherapy
11/2004
1DBPT regimen
06/2000